SLC12A2 and central nervous system cancer: Recently, a study showed that blockade of NKCC1 could increase Temozolomide (a conventional chemotherapy drug) induced glioma apoptosis and reduced astrogliosis, which presented the potential therapeutic effect of NKCC133.